The underlying inflammatory cause for increased sClever-1 is further supported by our data showing the induction of the release by IFNγ/TNFα, the sustained sClever-1 levels after tumor surgery and the different inflammatory cytokine profiles observed in breast cancer patients. The gene discussed is IFNG; the disease is breast carcinoma.